Elizabeth Parrish is CEO of BioViva, a Seattle-based biotech company working to develop treatments to slow the ageing process. In April, the company revealed that Parrish herself had undergone “the first gene therapy successful against human ageing”. The treatment, it claimed, had reversed the biological age of her immune cells by 20 years.

- PhD student researching Aging, Mitochondria, and Regenerative Medicine -
I currently write for The Conversation (http://bit.ly/13WVyUW) and I have
written for The Guardian (http://bit.ly/13WVtRh) - Ringleader of the Oxford
University Scientific Society - Co-conspirator at the Oxford Transhumanism
and Emerging Technologies - Designing exciting events with the British
Science Association Oxford - Advisory Board member at Lifeboat Foundation's
Life Extension Board, and the Sustainability Board - Also, I am an Ultimate
(frisbee) enthusiast - Yes, unfortunately that's me trying to catch the
frisbee